The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I study of nanoparticle albumin-bound sirolimus (NAB-S) combined with pazopanib (PAZO) in patients with advanced soft tissue sarcoma (STS).
 
Lee D. Cranmer
Research Funding - AADi (Inst); Advenchen Laboratories (Inst); Astellas Pharma (Inst); CBA Research (Inst); Exelixis (Inst); Iterion Therapeutics (Inst); Lilly (Inst); Merck (Inst); Philogen (Inst); TRACON Pharma (Inst)
 
Elizabeth Trice Loggers
Research Funding - Ayala Pharmaceuticals (Inst); BioAtla (Inst); Epizyme (Inst); Karyopharm Therapeutics (Inst); SpringWorks Therapeutics (Inst)
 
Seth Pollack
Consulting or Advisory Role - AADi; Apexigen; Bayer; Daichii Sankyo; Deciphera; Epizyme; GlaxoSmithKline; Obsidian Therapeutics; Sensei Biotherapeutics; T-Knife
Speakers' Bureau - Deciphera
Research Funding - Obsidian Therapeutics (Inst)
 
Roxanne Moore
Travel, Accommodations, Expenses - Cogent Biosciences; Deciphera; SpringWorks Therapeutics
 
Rylee Johnson
No Relationships to Disclose
 
Shannon Maxwell
No Relationships to Disclose
 
Melanie Amador
No Relationships to Disclose
 
Michael J Wagner
Consulting or Advisory Role - AADi; Adaptimmune; Deciphera; Epizyme
Research Funding - Adaptimmune (Inst); Athenex (Inst); Deciphera (Inst); Foghorn Therapeutics (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Lilly (Inst); Presage Biosciences (Inst)
Travel, Accommodations, Expenses - Epizyme